Mechanisms of action of mifepristone when used for emergency contraception

Contraception

Volumn 68, Issue 6, 2003, Pages 471-476

  Gemzell Danielsson, Kristina ^a   Mandl, Irena ^a   Marions, Lena ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Emergency contraception; Endometrium; Mifepristone; Ovulation

Indexed keywords

LUTEINIZING HORMONE; MIFEPRISTONE;

CONFERENCE PAPER; CONTRACEPTION; CORPUS LUTEUM; DRUG EFFECT; DRUG MECHANISM; EMERGENCY CONTRACEPTION; ENDOMETRIUM; FEMALE GENITAL SYSTEM; FERTILIZATION; HUMAN; LUTEAL PHASE; NIDATION; NONHUMAN; OOCYTE MATURATION; OVARY FOLLICLE DEVELOPMENT; OVULATION INHIBITION; REPRODUCTION; SINGLE DRUG DOSE; SPERMATOZOON;

EID: 1642579547     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(03)00070-2     Document Type: Conference Paper

References (44)

1. Consensus statement of emergency contraception. Contraception 1995;52:211-3.
2. Morris J.M., van Wagenen G. Compounds interfering with ovum implantation and development. III. The role of estrogens. Am J Obstet Gynecol. 96:1966;804-813.
3. Yuzpe A.A., Lance W.J. Ethinylestradiol and dl-norgestrel as a potential contraceptive. Fertil Steril. 28:1977;932-936.
4. Lippes J., Tatum H.J., Maulik D., Sielezny M. Postcoital copper IUDs. Adv Plan Parent. 14:1979;87-94.
5. Randomized controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet. 352:1998;428-433.
6. Comparison of three single doses of mifepristone as emergency contraception: a randomised trial. Lancet. 353:1999;697-702.
7. Glasier A., Thong K.J., Dewar M., Mackie M., Baird D.T. Mifepristone (RU 486) compared with high-dose estrogen and progesterone for emergency postcoital contraception. N Engl J Med. 327:1992;1041-1044.
8. Webb A.M., Russell J., Elstein M. Comparison of Yuzpe regimen, danazol and mifepristone (RU486) in oral postcoital contraception. BMJ. 305:1992;927-931.
9. Xiao B.L., Von Hertzen H., Zhao H., Piaggio G. A randomized double-blind comparison of two single doses of mifepristone for emergency contraception. Hum Reprod. 17:2002;3084-3089.
10. Ashok P.W., Wagaarachi P.T., Flett G.M., Templeton A. Mifepristone as a late post-coital contraceptive. Hum Reprod. 16:2001;72-75.
11. von Hertzen H., Piaggio G., Ding J., et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception a WHO multicentre randomised trial . Lancet. 7:2002;360. (9348):1803-10.
12. Swahn M.L., Johannisson E., Daniore V., de la Torre B., Bygdeman M. The effect of RU 486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium. Hum Reprod. 3:1988;915-921.
13. Yang J., Serres C., Philibert D., Robel P., Baulieu E.E., Jouannet P. Progesterone and RU486 opposing effects on human sperm . Proc Natl Acad Sci. 91:1994;529-533.
14. Blackmore P.F., Neulen J., Lattanzio F., Beebe S.J. Cell surface binding sites for progesterone mediate calcium uptake in human sperm. J Biol Chem. 266:1991;18655-18659.
15. Spitz I.M., Croxatto H.B., Salvatierra A.M., Heikinheimo O. Response to intermittent RU486 in women. Fertil Steril. 59:1993;971-975.
16. Marions L., Hultenby K., Lindell I., Sun X., Stabi B., Gemzell Danielsson K. Emergency contraception with mifepristone and levonorgestrel mechanism of action . Obstet Gynecol. 100:2002;65-71.
17. Liu J.H., Garzo G., Morris S., Stuenkel C., Ulmann A., Yen S.S. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486. J Clin Endocrinol Metab. 65:1987;1135-1140.
18. Shoupe D., Mishell D.R., Page M.A., Madkour H., Spitz I.M., Lobo R.A. Effects of the antiprogesterone RU 486 in normal women. II. Administration in the late follicular phase. Am J Obstet Gynecol. 157:1987;1421-1426.
19. Croxatto H.B., Salvatierra A.M., Fuentealba B., Leiva L. Follicle stimulating hormone-granulosa cell axis involvement in the antifolliculotrophic effect of low dose mifepristone (RU486). Hum Reprod. 10:1995;1987-1991.
20. Iwai T., Nanbu Y., Iwai M., Taii S., Fujii S., Mori T. Immunohistochemical localisation of oestrogen receptors and progesterone receptors in the human ovary throughout the menstrual cycle. Virchows Arch A Pathol Anat Histopathol. 417:1990;369-375.
21. Permezel J.M., Lenton E.A., Roberts I., Cooke I.D. Acute effects of progesterone and the antiprogestin RU 486 on gonadotropin secretion in the follicular phase of the menstrual cycle. J Clin Endocrinol Metab. 68:1989;960-965.
22. Batista M.C., Cartledge T.P., Zellmer A.W., Nieman L.K., Merriam G.R., Loriaux D.L. Evidence for a critical role of progesterone in the regulation of the midcycle gonadotropin surge and ovulation. J Clin Endocrinol Metab. 74:1992;565-570.
23. Batista M.C., Cartledge T.P., Zellmer A.W., Nieman L.K., Loriaux D.L., Merriam G.R. The antiprogestin RU 486 delays the midcycle gonadotropin surge and ovulation in gonadotropin-releasing hormone-induced cycles. Fertil Steril. 62:1994;28-34.
24. Messinis I.E., Templeton A. The effect of the antiprogestin mifepristone (RU486) on maturation and in-vitro fertilization of human oocytes. Br J Obstet Gynaecol. 95:1988;592-595.
25. Smotrich D.B., Stillman R.J., Widra E.A., et al. Immunocytochemical localization of growth factors and their receptors in the human pre-embryos and Fallopian tubes. Hum Reprod. 11:1996;184-190.
26. Mahmood T., Saridogan E., Smutna S., Habib A.M., Djahanbakhch O. The effect of ovarian steroids on epithelial ciliary beat frequency in the human Fallopian tube. Hum Reprod. 13:1998;2991-2994.
27. Christow A., Sun X., Gemzell-Danielsson K. Effect of mifepristone and levonorgestrel on expression of steroid receptors in the human Fallopian tube. Mol Hum Reprod. 8:2002;333-340.
28. Gemzell Danielsson K., Swahn M.L., Svalander P., Bygdeman M. Early luteal phase treatment with RU486 for fertility regulation. Hum Reprod. 8:1993;870-873.
29. Gemzell Danielsson K., Svalander P., Swahn M.L., Johannisson E., Bygdeman M. Effects of a single-postovulatory dose of RU486 on endometrial maturation in the implantation phase. Hum Reprod. 9:1994;2398-2404.
30. Gemzell Danielsson K., Swahn M.L., Bygdeman M. The effect of various doses of mifepristone on endometrial leukaemia inhibitory factor expression in the midluteal phase - an immunohistochemical study. Hum Reprod. 12:1997;1293-1297.
31. Marions L., Gemzell Danielsson K., Swahn M.L., Bygdeman M. The effect of antiprogestin on integrin expression in human endometrium an immunohistochemical study . Hum Reprod. 4:1998;491-495.
32. Kumar S., Zhu L.J., Polihronis M., Cameron S.T., et al. Progesterone induces calcitonin gene expression in human endometrium within the putative window of implantation. J Clin Endocrinol Metab. 83:1998;4443-4450.
33. Cameron S.T., Critchley H.O., Buckley C.H., Kelly R.W., Baird D.T. Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation. Fertil Steril. 67:1997;1046-1053.
34. Gemzell Danielsson K., Hamberg M. The effect of antiprogestin (RU 486) and prostaglandin biosynthesis inhibitor (naproxen) on uterine fluid prostaglandin F2α concentration. Hum Reprod. 9:1994;1626-1630.
35. Swahn M.L., Bygdeman M., Xing S., Cekan S., Masironi B., Johannisson E. The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium. Hum Reprod. 5:1990;402-408.
36. Gemzell Danielsson K., Westlund P., Swahn M.L., Bygdeman M., Seppala M. Effect of low weekly doses of mifepristone on ovarian function and endometrial development. Hum Reprod. 11:1996;256-264.
37. Marions L., Gemzell Danielsson K., Swahn M.L., Bygdeman M. Contraceptive efficacy of low doses of mifepristone. Fertil Steril. 70:1998;813-816.
38. Marions L., Viski S., Gemzell Danielsson K., et al. Contraceptive efficacy of daily administration of 0.5 mg mifepristone. Hum Reprod. 14:1999;2788-2790.
39. Ottander U., Hosokawa K., Liu K., Bergh A., Ny T., Olofsson J. A putative stimulatory role for progesterone acting via progesterone receptors in the steroidogenic cells of the human corpus luteum. Biol Reprod. 62:2000;655-663.
40. Schaison G., George M., Lestrat N., Reinberg A., Baulieu E.E. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women. J Clin Endocrinol Metab. 61:1985;484-489.
41. Garzo V.G., Liu J., Ulmann A., Baulieu E., Yen S.S.C. Effects of an antiprogesterone (RU 486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle. J Clin Endocrinol. 66:1988;508-517.
42. Mais V., Kazer R.R., Cetel N.S., Rivier J., Vale W., Yen S.S.C. The dependency of folliculogenesis and corpus luteum function on pulsatile gonadotropin secretion in cycling women using a gonadotropin-releasing hormone antagonist as a probe. J Clin Endocrinol Metab. 62:1986;1250-1255.
43. Swahn M.L., Bygdeman M., Chen J.-K., et al. Once-a-month treatment with a combination of mifepristone and the prostaglandin analogue misoprostol. Hum Reprod. 14:1999;485-488.
44. Ghosh D., Lalitkumar P.G.L., Wong V.J., Hendrickx A.G., Sengupta J. Preimplantation embryo morphology following early luteal phase anti-nidatory treatment with mifepristone (RU486) in the rhesus monkey. Hum Reprod. 5:2000;180-188.